未登录 分享 收藏
Disitamab vedotin (DV) plus toripalimab (T) in unresectable locally advanced or metastatic urothelial carcinoma (la/mUC): Long-term outcomes from a phase Ib/II study Disitamab vedotin (DV) 联合 toripalimab (T) 治疗不可切除局部晚期或转移性尿路上皮癌 (la/mUC) 的长期疗效:一项 Ib/II 期研究的结果 Zhou, L.; Yang, K.; Zhang, S.; Yan, X.; Li, S.; Xu, H.; Li, J.; Chi, Z.; Mao, L.; Lian, B.; Bixia, T.; Wang, X.; Guo, H.; He, Z.; Guo, J.; Sheng, X. 分享 收藏
Stability of industrial gallium-doped Czochralski silicon PERC cells and wafers Niewelt, T.; Maischner, F.; Kwapil, W.; Khorani, E.; Pain, S. L.; Jung, Y.; Hopkins, E. C. B.; Frosch, M.; Altermatt, P. P.; Guo, H.; Wang, Y. C.; Grant, N. E.; Murphy, J. D. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Lack of effects of evidence-based, individualised counselling on medication use in insured patients with mild hypertension in China: a randomised controlled trial Di, Mengyang; Mao, Chen; Yang, Zuyao; Ding, Hong; Liu, Qu; Liu, Shuiming; Guo, Hongbo; Jiang, Kunhua; Tang, Jinling 分享 收藏
分享 收藏
分享 收藏
分享 收藏